ELOVL5 and breast cancer: Unlike maternal CS, BS did not downregulate expression of genes involved in de novo lipogenesis including Acc2, Fads1, Elovl5 or their upstream regulators Srebp1c and Chrebp1 (PS > 0.05) versus BC (Fig. 4c).